In an initial small study of blast/leukemic phase of preexisting JAK2- mutated MPN, five of 16 patients displayed IDH mutations: Three of these patients displayed an R132C IDH1 mutation, whereas two exhibited an R140Q IDH2 mutation [67]. Here, IDH2 is linked to myeloproliferative neoplasm.